Literature DB >> 10997721

Acute renal response to the non-peptide vasopressin V2-receptor antagonist SR 121463B in anesthetized rats.

D Y Huang1, I Pfaff, C Serradeil-Le Gal, V Vallon.   

Abstract

Vasopressin V2-receptor antagonists are promising agents for the use in water-retaining diseases. Potential renal mechanisms of action include effects on water permeability in the collecting duct as well as on electrolyte transport in the thick ascending limb of Henle's loop (TALH). To elucidate sites of action upstream of the distal tubule, e.g., in TALH, micropuncture experiments were performed in anesthetized rats during application of the V2-receptor antagonist SR 121463B. As compared to vehicle-treated rats, SR 121463B (0.3 mg/kg i.v.) did not affect mean arterial blood pressure (means +/- SEM, n=10 rats per group: 108+/-4 mmHg vs. 107+/-4 mmHg), whole kidney GFR (1.1+/-0.1 ml/min vs. 1.1+/-0.1 ml/min), or whole kidney fractional reabsorption (FR) of potassium (66+/-5% vs. 68+/-4%). The drug, however, reduced whole kidney FR of fluid (92+/-1% vs. 99+/-1%), increased urinary flow rate (84+/-7 microl/min vs. 8+/-1 microl/min) and electrolyte-free-water clearance (72+/-8 microl/min vs. 2+/-1 microl/min), and reduced urinary osmolality (148+/-11 mosmol/kg vs. 1,200+/-185 mosmol/kg). This pronounced diuretic response was associated with a minor reduction in whole kidney FR of sodium (99.6+/-0.1% vs. 99.9+/-0.1%) and chloride (98.3+/-0.2% vs. 98.9+/-0.1%). As compared to vehicle application, SR 121463B did not significantly alter single nephron GFR (39+/-2 nl/min vs. 39+/-1 nl/min, n=22 and 23 nephrons, respectively) or the FR up to the early distal tubule of fluid (76+/-2% vs. 76+/-1%), sodium (92+/-1% vs. 93+/-1%), potassium (91+/-1% vs. 90+/-1%) or chloride (90+/-1% vs. 91+/-1%). Together these data indicate a predominant aquaretic effect of SR 121463B which is located downstream of the early distal tubule. This response is compatible with blockade of vasopressin V2-receptors in the collecting duct and, as directly demonstrated by immunohistochemistry, subsequent retrieval of aquaporin-2 from apical plasma membrane, which inhibits water permeability and transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997721     DOI: 10.1007/s002100000282

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat.

Authors:  Takahiro Masuda; Yuko Watanabe; Keiko Fukuda; Minami Watanabe; Akira Onishi; Ken Ohara; Toshimi Imai; Hermann Koepsell; Shigeaki Muto; Volker Vallon; Daisuke Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-23

2.  Impaired ability to increase water excretion in mice lacking the taurine transporter gene TAUT.

Authors:  Dan Yang Huang; Krishna M Boini; Philipp A Lang; Florian Grahammer; Michael Duszenko; Birgit Heller-Stilb; Ulrich Warskulat; Dieter Häussinger; Florian Lang; Volker Vallon
Journal:  Pflugers Arch       Date:  2005-10-26       Impact factor: 3.657

3.  Vasotocin and vasopressin stimulation of the chloride secretion in the human bronchial epithelial cell line, 16HBE14o-.

Authors:  Karen Bernard; Stéphanie Bogliolo; Jordi Ehrenfeld
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Expression and insights on function of potassium channel TWIK-1 in mouse kidney.

Authors:  Xin Nie; Isabelle Arrighi; Brigitte Kaissling; Imke Pfaff; Jeffrey Mann; Jacques Barhanin; Volker Vallon
Journal:  Pflugers Arch       Date:  2005-07-16       Impact factor: 3.657

5.  Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.

Authors:  Frederic Chagnon; Vishal S Vaidya; Gerard E Plante; Joseph V Bonventre; Alfred Bernard; Chantal Guindi; Olivier Lesur
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

6.  Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.

Authors:  Julie Perucca; Daniel G Bichet; Pascale Bardoux; Nadine Bouby; Lise Bankir
Journal:  J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 10.121

7.  Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume.

Authors:  Takahiro Masuda; Shigeaki Muto; Keiko Fukuda; Minami Watanabe; Ken Ohara; Hermann Koepsell; Volker Vallon; Daisuke Nagata
Journal:  Physiol Rep       Date:  2020-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.